MarketCapTrends
NVCR

NovoCure Ltd. (NVCR)

NASDAQ · Healthcare

NovoCure Ltd. annual/quarterly long term debt history from 2015 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • NovoCure Ltd. long term debt for the quarter ending December 31, 2025 were 195.0M, a 100.46% increase year-over-year.
  • NovoCure Ltd. long term debt for 2025 were 195.0M, a 100.46% increase from 2024.
  • NovoCure Ltd. long term debt for 2024 were 97.3M, a 82.89% decrease from 2023.
  • NovoCure Ltd. long term debt for 2023 were 568.8M, a 0.59% increase from 2022.
  • NovoCure Ltd. long term debt for 2022 were 565.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
NovoCure Ltd. Annual Long Term Debt (Millions of US $)
2025$195
2024$97
2023$569
2022$566
2021$562
2020$430
2019$149
2018$149
2017$97
2016$96
2015$23
NovoCure Ltd. Quarterly Long Term Debt (Millions of US $)
2025-12-31$195
2024-12-31$97
2023-12-31$569
2022-12-31$566
2021-12-31$562
2020-12-31$430
2019-12-31$149
2018-12-31$149
2017-12-31$97
2016-12-31$96
2015-12-31$23

NovoCure Ltd. Long Term Debt — FAQ

NovoCure Ltd. (NVCR) long term debt over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see NVCR's long term debt history?

The chart and table above show NovoCure Ltd.'s long term debt by year and by quarter, including the growth rate.